Location of Repository

Six Years Follow-up of the Levels of TNF-α and IL-6 in Patients with Complex Regional Pain Syndrome Type 1

By Feikje Wesseldijk, Frank J. P. M. Huygen, Claudia Heijmans-Antonissen, Sjoerd P. Niehof and Freek J. Zijlstra

Abstract

In an earlier study, levels of the proinflammatory cytokines TNF-α and IL-6 are higher in blisters fluid from the complex regional pain syndrome type 1 (CRPS1) side obtained at 6 and 30 months (median) after the initial event. The aim of this follow-up study is to determine the involvement of these cytokines in long lasting CRPS1. Twelve CRPS1 patients, with median disease duration of 72 months, participated. The levels of TNF-α and IL-6 were measured in blister fluid; disease activity was reevaluated by measuring pain and differences in temperature, volume, and mobility between both extremities. Differences in levels of IL-6 and TNF-α and mobility between both sides were significantly decreased. Pain and differences in temperature and volume were not significantly altered. No correlation was found between the cytokines and the disease characteristics. These results indicate that IL-6 and TNF-α are only partially responsible for the signs and symptoms of CRPS1

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2441694
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2006). a n e k e r ,O .H .G .W i l d e r - S m i t h ,P .S c h r o m b g e s ,a n dH .M . Oerlemans, “Impairments as measured by ISS do not greatly change between one and eight years after CRPS 1 diagnosis,”
    2. (2000). An accurate and simple method for measurement of paw edema,”
    3. (1992). Assessment of an infra-red non-contact sensor for routine skin temperature monitoring: a preliminary study,”
    4. (1983). Assessment of chronic pain—I: aspects of the reliability and validity of the visual analogue scale,”
    5. (2005). Changes in cerebrospinal fluidlevelsofpro-inflammatorycytokinesinCRPS,”Pain,vol.
    6. (2005). Complex regional pain syndrome,”
    7. (2003). Complex regional pain syndrome: mystery explained?”
    8. (2004). Computer-assisted skin videothermography is a highly sensitive quality tool in the diagnosis and monitoring of complex regional pain syndrome type 1,”
    9. (2007). Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain,”
    10. (1996). Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid,”
    11. (1997). Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy,”
    12. (2002). Evidence for local inflammation in complex regional pain syndrome type 1,”
    13. (1999). External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria,”
    14. (2004). Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome,”
    15. (2006). HeijmansAntonissen,S.Niehof,andF.J.Zijlstra,“Increasedendothelin1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1,”
    16. (2008). Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1,”
    17. (2008). Increased plasma serotonin in complex regional pain syndrome type 1,” Anesthesia
    18. (2005). Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines,”
    19. (1991). L o w e ,S .N .W a l k e r ,a n dR .C .M a c C a l l u m ,“ C o n fi r m i n g the theoretical structure of the McGill pain questionnaire in acute clinical pain,”
    20. (2004). Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1,” Immunology Letters,
    21. (2006). Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1,”
    22. (2006). N i e h o f
    23. (1998). Neurogenic inflammation and reflex sympathetic dystrophy (in vivo and in vitro assessment
    24. (1998). Neurogenic inflammation in an animal model of neuropathic pain,”
    25. (2001). Neuroimmune alterations in the complex regional pain syndrome,”
    26. (2000). Neurological findings in complex regional pain syndromes— analysis of 145 cases,”
    27. (2005). Patients initially diagnosed as ‘warm’ or ‘cold’ CRPS 1 show differences in central sensory processing some eight years after diagnosis: a quantitative sensory testing study,”
    28. (2002). Reflex sympathetic dystrophy,” Current Rheumatology Reports,v o l .4 ,n o .2 ,p p .
    29. Tumor necrosis factor-α and interleukin-6 are not correlated with the characteristics of complex regional painsyndrometype1in66patients,”EuropeanJournalofPain.
    30. (1993). V e l d m a n ,H .M .R e y n e n ,I .E .A r n t z ,a n dR
    31. (2000). van d e rL a a n ,J .L .S e v e r e n s ,a n dJ .A .G o r i s ,“ A d j u v a n tp h y s i c a l therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I,”
    32. (1999). Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery,”
    33. (2001). Vascular abnormalities in reflex sympathetic dystrophy(CRPSI):mechanismsanddiagnosticvalue,”Brain,
    34. (2001). Which patients with chronic reflex sympathetic dystrophy are most likely to benefit from physical therapy?”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.